MedTrace Logo

Evaluation of Physician-based Decision Support

NCT03443713 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2020-03-18

Study results available
· View outcomes & findings →

Summary

The goal of this study is to assess the impact of physician-driven insulin setting changes in type 1 patients using multiple daily injection insulin therapy with exercise. This is a short outpatient study with multiple outpatient and home exercise sessions with an assigned type of exercise.

Conditions

  • Type 1 Diabetes Mellitus
  • MDI
  • CGM
  • Exercise

Interventions

DEVICE

Dexcom G6 CGM

Subjects will wear a Dexcom G6 CGM for the 28 days they are on study.

Sponsors & Collaborators

  • DexCom, Inc.

    collaborator INDUSTRY

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Jessica Castle, MD · Oregon Health and Science University

  • Peter Jacobs, PhD · Oregon Health and Science University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-18
Primary Completion
2019-05-08
Completion
2019-05-08
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03443713 on ClinicalTrials.gov